Related Experiment Video
Updated: May 17, 2026
12:11
A Rhodopsin Transport Assay by High-Content Imaging Analysis
Published on: January 16, 2019
Microarray-based mutation detection and phenotypic characterization in Korean patients with retinitis pigmentosa
Cinoo Kim1, Kwang Joong Kim, Jeong Bok
1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
Molecular Vision
|October 11, 2012
Summary
Microarray genotyping is not ideal for rare retinitis pigmentosa (RP) mutations but can identify known ones. Clinical features of RP vary significantly with specific mutations, highlighting the need for novel gene discovery.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Retinitis pigmentosa (RP) is a group of inherited retinal diseases.
- Accurate genetic diagnosis is crucial for understanding RP.
- Microarray-based genotyping offers a high-throughput approach for genetic analysis.
Purpose of the Study:
- To assess the utility of microarray-based genotyping for detecting RP-causing mutations.
- To characterize the clinical phenotypes associated with identified mutations.
Main Methods:
- DNA from 336 RP patients and 360 controls was analyzed using the GoldenGate assay.
- The assay targeted 95 known mutations across 28 RP genes.
- Direct sequencing confirmed identified mutations, followed by segregation analysis and detailed phenotypic characterization.
Main Results:
- Ten RP mutations in five genes (PRPF3, RHO, PDE6B, PRPH2, RP1) were found in 7.7% of patients and 1.7% of controls.
- The PDE6B p.H557Y mutation was the most frequent (2.5%).
- Phenotypic severity varied, with RP1 p.D984G causing the most severe and RHO p.D190N the mildest phenotypes.
Conclusions:
- The GoldenGate assay is not efficient for detecting rare RP mutations but is reliable for common variants.
- Clinical manifestations of RP are mutation-dependent.
- Continued research into novel RP genes and mutations is essential for improving diagnostic accuracy.